(B-D) Py2T tumor-bearing mice were treated with nintendanib or sunitinib during 21 days, and mice were sacrificed at day 35 post tumor cell injection. Tumor weights at the experimental end point (A), microvessel densities (B) and CD31-positive area fractions per field of view (C) determined by immunofluorescence staining are shown. N = 3-6 mice per group. Statistical significance was calculated using Mann-Whitney U test. n.s., non significant; *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001. 
(E) Expression of different glycolysis genes in Py2T cells cultured in hypoxic conditions
analyzed by quantitative RT-PCR. Data are normalized to cells cultured in normoxic conditions. Shown are means ± SEM. N = 4. Statistical significance was calculated using Student t test. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001. (H-J) Single channels corresponding to MCT4/Glut1, pimonidazole/Glut1 and pimonidazole/MCT4 co-stainings presented in Figure 4E , 4G and 4I, respectively. Pimo., pimonidazole; Veh., vehicle; Nint., nintedanib. Scale bars, 100 µm. Statistical significance was calculated using Mann-Whitney U test. n.s., non significant; *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001. Statistical significance was calculated using Mann-Whitney U test. n. s., non significant; *, P < 0.05; **, P < 0.01; ****, P < 0.0001.
Supplemental Experimental Procedures
Therapy studies Treatment of Py2T tumor-bearing mice was initiated when tumors reached a measurable size (15-20mm 3 ) to allow a thorough stratification into experimental groups with similar mean tumor volumes. Nintedanib (kindly provided by Boehringer Ingelheim) was formulated in 0.5% natrosol hydroxyethylcellulose (Boehringer Ingelheim) and administered daily at 50 mg/kg body weight (BW) by oral gavage. Rip1Tag2 transgenic mice were treated with the same regimen from 10 weeks of age onwards (Bill et al., 2015) . Sunitinib L-malate (LC Laboratories) was administered at 40 mg/kg in carboxymethylcellulose daily by oral gavage as described (Paez-Ribes et al., 2009 ). 3-(3-pyridinyl)-1-(4-pyridinyl)-2-propen-1-one (3PO; Axon Medchem, 2175) was dissolved in a 10% EtOH, 40% PEG, 50% PBS solution and administered at 70 mg/kg daily by intraperitoneal (i.p) injection. Treatment was initiated at day 8 of nintedanib treatment. Animals of the experimental arms were euthanized by CO 2 (or cervical dislocation for hypoxia studies), either time-or size-matched to the control treatment. Primary tumors were dissected and processed for further analyses.
RNA isolation RNA of sorted endothelial cells was isolated using the Absolutely RNA Nanoprep Kit (Stratagene) following the manufacturer's recommendations. RNA of sorted tumor cells was isolated using TRIzol ® LS reagent (Ambion ® ) and RNA Easy Micro Kit (Qiagen). To isolate RNA from whole tumors, previously snap frozen tissues were homogenized in Tri Reagent (Sigma-Aldrich) using a POLYTRON ® (Kinematica) and isolated following the manufacturer's recommendations.
Quantitative RT-PCR RNA was reverse transcribed using M-MLV reverse transcriptase (Promega) and quantitative PCR was performed using SYBR-green PCR MasterMix (Applied Biosystems) in a StepOne Plus PCR machine (Applied Biosystems). Fold change expression was determined by the comparative Ct method (∆∆C t ) normalized to 60S Ribosomal protein L19 expression. Primers for quantitative PCR are listed in Table S1 .
Lactate assay
Lactate concentration was determined on tumor lysate by using the L-Lactate Assay Kit from Abcam (ab65331) following the manufacturer's recommendations.
Immunoblotting
Immunoblotting has been performed as previously described (Zumsteg et al., 2012) . The following antibodies were used: MCT4 (Santa Cruz Biotechnology, sc-50329, 1:200) and actin (Santa Cruz Biotechnology, sc-1616, 1:1000).
Lentiviral infection
Lentiviral plasmids containing short-hairpin RNAs #1-5 (shRNA) against mouse MCT4 were purchased from Sigma-Aldrich (Mission Non-Targeting shRNA control vector: SHC002; shMCT4 #1: TRCN0000079653, shMCT4 #2: TRCN0000079654, shMCT4 #3: TRCN0000079655, shMCT4 #4: TRCN0000079656, shMCT4 #5 TRCN0000079657). In order to produce lentiviral particles, HEK293T cells were transfected with the shRNA containing plasmids, the helper vectors pMDL and pREV and the envelope encoding plasmid pVSV using FugeneHD. Virus containing supernatant was conditioned for 2 days, filtered through a 0.45 µm filter, gently mixed with Lenti-X Concentrator (Clontech), and followed by an overnight incubation at 4°C and subsequent centrifugation the next day. The viruscontaining pellet was resuspended in fresh complete DMEM medium, 8 ng/ml polybrene was added and Py2T cells were infected. Successfully transfected cells were selected by puromycin treatment (5 µg/ml). Knockdown efficiency was determined by measuring hypoxia-induced (96h, 1% O 2 ) MCT4 mRNA expression by quantitative RT-PCR.
Hypoxia and vessel functionality
To assess functional blood vessel perfusion, 100 µg of fluorescein-labeled Lycopersicon esculentum (tomato) lectin (Vector Laboratories, GL-1171) was injected into the tail vein. Two minutes later, mice were terminally anaesthetized and five minutes later perfused via the left cardiac ventricle first with cold 4% PFA and subsequently with cold PBS. To identify hypoxic tumor areas, 60 mg/kg pimonidazole-HCl (Hypoxyprobe Omni Kits, Hypoxyprobe, Inc.) dissolved in PBS was injected i.p. 1 hour before euthanizing the animals by cervical dislocation.
Immunofluorescence microscopy analysis
Tumors were fixed in 4% PFA for 2 hours followed by overnight incubation in 20% sucrose to cryopreserve the tissue, both at 4°C. Then, tumors were snap frozen in Tissue-Tek OCT compound (Thermo Scientific) and stored at -80°C. Eight µm thick tumor sections were cut, dried for 30 minutes, rehydrated with PBS, permeabilized with 0.2% Triton X-100 for 20 minutes and blocked with 5% normal goat serum (NGS; Sigma-Aldrich) for 1 hour. As an exception, when performing stainings with anti-cCasp3 antibodies, blocking was performed using 20% NGS. When using a goat primary antibody, sections were blocked with 5% bovine serum albumin. Subsequently, primary and secondary antibodies were diluted in blocking solution and incubated overnight at 4°C and 1 hour at room temperature, respectively. Images were acquired with a Leica DMI 4000 microscope.
Antibodies used: rabbit anti-cleaved Caspase-3 (cCasp3; Cell Signaling, 9664, 1:50), rat anti-CD31 (BD Pharmingen, 550274, 1:50), rabbit anti-NG2 (Chemicon, AB5320, 1:100), rabbit anti-phospho Histone H3 (pH3; Millipore, 06-570, 1:200), rabbit anti-pimonidazole (Hypoxyprobe, 1:25), mouse anti-pimonidazole-FITC (Hypoxyprobe, 1:25), goat anti-MCT1 (Santa Cruz, sc-14917, 1:50), rabbit anti-MCT4 (Santa Cruz, sc-50329, 1:50), goat anti-MCT4 (Santa Cruz, sc-14930, 1:50), goat anti-Glut1 (Santa Cruz, sc-1605, 1:50), rabbit antiCoxIV (Cell Signaling, 4850, 1:100) and rabbit anti-PGC1α (Millipore, AB3242, 1:300). Primary antibody binding was detected by incubating the histological sections with secondary antibodies directed against the respective species of the primary antibodies for 1 hour at room temperature, diluted 1:200 in blocking solution. Secondary antibodies were fluorescently tagged with Alexa 488, Alexa 568 or Alexa 633 (Molecular probes). Subsequently, nuclei were stained with 4′,6-Diamidin-2-phenylindol (DAPI; Sigma-Aldrich; 1:10,000) followed by mounting the slides with Dako mounting medium (Dako).
Flow cytometry
Freshly dissected Py2T primary tumors were immediately minced into small pieces and digested for 30 minutes at 37°C on a bacterial shaker in DMEM (Sigma-Aldrich) supplemented with Nu-Serum Growth Medium Supplement (6%; Corning), DNase I (200 µg/ml; Roche), Dispase II (1.2mg/ml; Roche) and Collagenase D (1.2 mg/ml; Roche). To achieve a single cell suspension, the digested tissue was first passed through a 70 µm and subsequently through a 40 µm cell strainer (Corning). Cells were washed in FACS-buffer (5% fetal bovine serum in PBS; Sigma-Aldrich Figure S3D ). Endothelial cells were directly sorted into the lysis buffer of the Absolutely RNA Nanoprep Kit (Stratagene) by gating on CD31 + /CD45 -/Podoplanin -cells ( Figure S3D ).
Annexin V staining
Py2T WT cells or Py2T CRISPR MCT4 clones #1 and #2 were cultured for 3 days under normoxic or hypoxic conditions. Both floating and attached cells were collected and washed in PBS. 1.10 6 cells were resuspended in 1X binding buffer and stained using Cy5 AnnexinV (BD Pharmingen, # 559934, dilution 1/20) and 2 µg/ml DAPI for 20 min in the dark. 50,000 cells/sample were analyzed by flow cytometry (FACS Canto, Becton Dickinson).
EdU staining
Py2T WT cells or Py2T CRISPR MCT4 clones #1 and #2 were cultured for 3 days under normoxic or hypoxic conditions. Cells were incubated with 10 µM EdU for 30 min. After trypsinization 1.10 6 cells were stained using EdU-Flow cytometry 488 Kit (Base-Click, BCK-FC488) following manufacturer's instruction. Prior to FACS acquisition cells were incubated 2h at 37°C in presence of 10 µg/ml RNAse (Roche, 11119915001) and 50 µg/ml propidium iodide (Sigma-Aldrich, 81845). 50,000 cells/sample were analyzed by flow cytometry (FACS Canto, Becton Dickinson).
Extracellular metabolic flux analysis
For analysis of the OCR (in pmol/min) and ECAR (in mpH/min), the Seahorse XFe-96 metabolic extracellular flux analyzer was used (Seahorse Bioscience, North Billerica, MA, USA). Py2T WT cells or Py2T CRISPR MCT4 clones #1 and #2 were plated at a density of 2,500 cells per well and expanded for 48 hours under normoxic (21% O 2 ) or hypoxic (1% O 2 ) conditions. Cells were treated with nintedanib for 48h or with 3PO for 3h. Prior to performing the metabolic assays, medium was exchanged for serum-free unbuffered RPMI-1640 medium (Sigma-Aldrich). Perturbation profiling of mitochondrial respiratory parameters was performed by the addition of oligomycin (1 µM), Carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone (FCCP) (2 µM) and rotenone (1 µM) and measuring changes in OCR. Glycolytic parameters were assessed independently in parallel wells by the sequential addition of glucose (10 mM), oligomycin (1 µM) and 2-deoxyglucose (2-DG, 50 mM, all Sigma-Aldrich) to cells maintained in glucose-free unbuffered RPMI-1640 medium (Sigma-Aldrich). Metabolic parameters were calculated following the manufacturer's recommandation. Additionally, OCR and ECAR were assessed under hypoxic conditions (1% O2) using the Seahorse XFe-96 metabolic extracellular flux analyzer placed in a Hypoxia Workstation (SCI-tive, Ruskinn Technology, Bridgend, UK). Unbuffered medium (± glucose) was equilibrated to hypoxia overnight and layered onto) Py2T WT cells or Py2T CRISPR MCT4 clones #1 and #2 plated as described above. Metabolic parameters were assessed as per under normoxic conditions and there were additional control wells where 1 M sodium sulfite was injected into calibrant fluid to provide a 'zero' oxygen reference parameter for the software algorithm to calculate OCR. 
Microarray analysis
Total RNA preparations of flow cytometry-sorted tumor and endothelial cells were analyzed using an Agilent 2100 bioanalyzer. Target synthesis was performed using the following suite of kits provided by Nugen (San Carlos, USA): WT-Ovation Pico (Cat# 3300), WT-Ovation Exon (Cat# 2000) and FL-Ovation Biotin V2 (Cat# 4200). The hybridization cocktail (200µl) containing fragmented biotin-labeled target DNA at a final concentration of 25ng/µl was transferred into Affymetrix GeneChip MoGene-1_0-st-v1 (Affymetrix) and incubated at 45°C on a rotator in a hybridization oven 640 (Affymetrix) for 17 h at 60 rpm. The arrays were washed and stained on a Fluidics Station 450 (Affymetrix) by using the Hybridization Wash and Stain Kit (Affymetrix, Cat# 900720) and the Fluidics Procedure FS450_0001. The GeneChips were processed with an Affymetrix GeneChip® Scanner 3000 7G (Affymetrix). DAT image files of the microarrays were generated using Affymetrix GeneChip Command Console (AGCC, version 0.0.0.676, Affymetrix).
Bioinformatic analysis
All microarray data were preprocessed and analyzed using R (software environment for statistical computing and graphics) version 3. The background-corrected and normalized gene expression datasets associated with the placebo-treated (UT), 1 week-treated (ST), and 3 week-treated (LT) samples were subjected to Gene Set Enrichment Analysis (GSEA) using GSEA V2.1.0. Three sets of analyses were conducted: ST versus UT, LT versus UT and ST versus LT. In all cases the default run-time arguments were used except for the "Permute" parameter that was set to "gene_set" (in order to accommodate less than 7 samples per class). In addition, analyses were conducted against the "MoGene_1_0_st.chip" microarray annotation and the following gene set libraries: "c2.cp.kegg.v4.0.symbols.gmt" and "c2.cp.reactome.v4.0.symbols.gmt" (Mootha et al., 2003; Subramanian et al., 2005) . Heat maps were generated using the heatmap.2 method provided by the gplots package. Boxplots were generated using the default boxplot method provided in R and based on the median background corrected and normalized expression value for each gene with respect to all samples within each sample class (UT, ST and LT). Additional statistical analyses were also carried out using GraphPad Prism 6 (GraphPad Prism Software Inc.). The microarray data has been deposited on Gene Expression Omnibus platform under the accession number GSE78698. 
Primers for qRT-PCR
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